Target intelligence / Profile preview

Semaphorin-4G (SEMA4G)

Target
SEMA4G
Molecular classification
Cell surface receptor, Semaphorin family protein, Signaling ligand, Transmembrane protein
01

Overview

Semaphorin-4G is a transmembrane protein belonging to the semaphorin family, characterized by a sema domain and an immunoglobulin domain in its extracellular portion. It acts as a cell surface receptor, most notably for plexin-B2 (PLXNB2), and is involved in critical biological processes such as axon guidance, immune cell maintenance, vascular growth, and regulation of cell motility. In mammals, Semaphorin-4G functions as a guidance ligand via multimeric receptor complexes, often involving plexin proteins. It is encoded by the SEMA4G gene on chromosome 10q24.31 and is implicated in developmental processes of the nervous system (for example, development of cerebellar granule cells) and in cancer biology, where it may have oncogenic or tumor-suppressive roles that are type-specific. Inherited or acquired variations in this gene have been associated with neurodevelopmental disorders, including autism spectrum disorder. No drugs are currently known to directly target Semaphorin-4G, and its mechanism as a therapeutic target remains to be fully defined.

Other names
Semaphorin-4GSEMA4GKIAA1619FLJ20590semaphorin-4Gsema domain, immunoglobulin domain (Ig), transmembrane domain (TM), short cytoplasmic domain(semaphorin) 4G
02

Biological functions

Axon guidanceCell motility and attachmentImmune cell maintenanceVascular growthModulation of tumor movementDevelopment of cerebellar granule cells
03

Disease associations

Cancer (oncogene or tumor suppressor functions proposed)Autism spectrum disorderPotentially other neurodevelopmental disorders
04

Safety considerations

Potential for context-dependent tumor-suppressor or oncogenic activitiesBroad, pleiotropic roles in nervous, cardiovascular, and immune systems may imply risk of off-target effects

Beyond the preview

Go deeper on Semaphorin-4G (SEMA4G).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semaphorin-4G (SEMA4G).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call